Company intelligence / Profile preview

Hotgen Biotech

Beijing, Beijing, Chinahotgenbiotech.com ↗
Ownership
Private
Employees
~1036
Development stage
Other
01

Overview

Hotgen Biotech has a broad commercial portfolio in in-vitro diagnostics with global regulatory approvals including CE IVDR and FDA EUA. Its COVID‑19 antigen self-test kits are widely distributed internationally. The company has entered the innovative drug space with SGC001 Injection in clinical trials for acute myocardial infarction and AA001 monoclonal antibody entering Phase 1 trials for Alzheimer's disease.

Therapeutic areas
NeurologyPsychiatryInfectious DiseasesOncologyCardiovascular
Modalities
AntibodyMonoclonal antibodyDiagnostic reagentSmall molecule (for diagnostics)Enzyme-linked immunoassay
Industry
Biotech
02

Drug pipeline

2 assets

SGT003

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

Shunjing Pharmaceutical/Professor Du Jie of Capital Medical University on SGC001 Injection developmentKLCII on AA001 mAb developmentMultiple academic collaborations via X-GEN AI New Drug Discovery Center

Beyond the preview

Go deeper on Hotgen Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hotgen Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call